Enveda Biosciences — Startup Profile

Finding medicines in the chemistry of nature.

HQ: Boulder, Colorado, United States | Founded: 2019 | Employees: Not publicly disclosed | Stage: Series D / private | Website: https://enveda.com

About

Enveda studies plants and other natural sources to find molecules that could become medicines. Its software helps researchers interpret complex biological data and choose promising compounds for laboratory and clinical testing.

The Take

Enveda is using modern data tools to revisit nature as a source of medicines. Its large funding rounds reflect confidence in the approach, but biotechnology timelines remain long and the ultimate test is whether candidates become safe, effective drugs.

Key Metrics

Founded: 2019
Latest funding: $150M
Status: Series D / private

Funding Rounds

Round: $150M (2025-09) — Not publicly disclosed
Round: $130M (2024-11) — Not publicly disclosed

Key People

Viswa Colluru
Pieter Dorrestein

Key Competitors

Insitro —
Schrödinger —
Generate Biomedicines —

Timeline Highlights

2024-11: Series C: $130M
2025-09: Series D: $150M

Similar Startups

Aether Biomachines — Designing industrial proteins with computers and biology.
Chai Discovery — The computer-aided design suite for molecules
Cellares — Automated manufacturing for cell therapies
Converge Bio — Generative AI for drug discovery and development
NewLimit — Reprogramming cells to treat age-related disease

More Biotech & Life Sciences Startups

Solugen — Bio-based chemical manufacturing via a modular enzymatic platform
Benchling — Unified R&D Cloud for life sciences
Aether Biomachines — Designing industrial proteins with computers and biology.

Category: Biotech & Life Sciences Startups